Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo - Report - MDSpire

Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo

  • By

  • Nathan Tsengele

  • Alfred Sodi Magudigana

  • Guy Gikelekele

  • Emmanuel Epenge

  • Guy Kangula

  • Eric Muteba Vukumuna

  • Abraham Mifundu Bilongo

  • Said Mbuku Nguala

  • Degani Banzulu Bomba

  • Gilbert Mananga Lelo

  • Adelin N’situ Mankubu

  • Jean Ikanga

  • May 22, 2026

  • 0 min

Share

Clinical Report: Linking Plasma Biomarkers of Neurodegeneration to Geriatric Depression

Overview

This study investigates the association between plasma biomarkers of neurodegeneration and geriatric depression in older adults in Kinshasa, Democratic Republic of the Congo. Findings indicate that GFAP and NfL are significantly associated with higher odds of geriatric depression, particularly in individuals with suspected Alzheimer's disease.

Background

Geriatric depression is prevalent among older adults, especially those with dementia, and can significantly impact morbidity. Understanding the relationship between neurodegenerative biomarkers and depression is crucial, particularly in sub-Saharan Africa where such studies are limited. This research aims to fill that gap by examining older adults with and without clinical dementia.

Data Highlights

BiomarkerOdds Ratiop-value
GFAP1.98 (1.17–3.67)0.02
NfL1.76 (1.06–3.20)0.04

Key Findings

  • 80% of participants suspected of having Alzheimer's disease exhibited geriatric depression.
  • Participants with dementia scored significantly lower on cognitive tests compared to those without dementia.
  • GFAP and NfL were significantly associated with higher odds of geriatric depression.
  • Other plasma biomarkers measured were not associated with depression.
  • High blood pressure was common in participants with suspected Alzheimer's disease (60%).

Clinical Implications

The findings suggest that monitoring GFAP and NfL levels may provide insights into the risk of geriatric depression in older adults, particularly those with dementia. This could inform clinical assessments and interventions in similar populations.

Conclusion

This study highlights the potential role of neurodegenerative biomarkers in understanding geriatric depression among older adults in sub-Saharan Africa, warranting further research in this area.

Related Resources & Content

  1. Yu et al., Brain, 2022 -- Plasma biomarker profiles in ageing: decoding neurodegeneration in vivo
  2. American Journal of Epidemiology, 2022 -- Linking Blood Neurodegenerative Biomarkers to Cognitive Abilities and Dementia in Older Adults: Insights from India (LASI-DAD) and the United States (HRS)
  3. Acta Neuropathologica, 2022 -- Plasma Biomarkers Associated with Alzheimer’s Disease: Links to Neuropathological Changes and Cognitive Decline
  4. Brain, 2022 -- Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder
  5. Alzheimer's Association Clinical Practice Guideline, 2025 -- Use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease
  6. Lancet, 2024 -- Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
  7. Frontiers, 2024 -- Preliminary reference values for Alzheimer’s disease plasma biomarkers in Congolese individuals
  8. Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings - PubMed
  9. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission - PubMed
  10. Frontiers | Preliminary reference values for Alzheimer’s disease plasma biomarkers in Congolese individuals with and without dementia

Original Source(s)

Related Content